UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
International journal of cancer, ISSN 0020-7136, 04/2019, Volume 144, Issue 8, pp. 1983 - 1995
rhabdoid tumor | SMARCB1 | ATRT | MYC | SWI/SNF complex | Life Sciences & Biomedicine | Oncology | Science & Technology | Chromatin - metabolism | Humans | Cellular Senescence - drug effects | SMARCB1 Protein - genetics | Rhabdoid Tumor - pathology | Cell Self Renewal - drug effects | Cell Self Renewal - genetics | Bone Morphogenetic Proteins - metabolism | Cell Transformation, Neoplastic - genetics | Female | Gene Expression Regulation, Neoplastic - drug effects | Bone Morphogenetic Proteins - genetics | Gene Expression Regulation, Neoplastic - genetics | Cellular Senescence - genetics | Proto-Oncogene Proteins c-myc - metabolism | Azepines - pharmacology | Triazoles - pharmacology | Xenograft Model Antitumor Assays | Teratoma - pathology | Animals | Rhabdoid Tumor - genetics | Mice, Nude | Cell Line, Tumor | Teratoma - genetics | Mice | Proto-Oncogene Proteins c-myc - genetics | Chromatin - genetics | Cell culture | Brain | Senescence | Brain tumors | Xenotransplantation | Transgenic | Myc protein | Subgroups | Chromatin remodeling | Organic chemistry | Molecular modelling | Depletion | Clonal deletion | Xenografts | Tumorigenesis | Inhibition | Children | Pluripotency | Tumors | Index Medicus
Journal Article
The Journal of pathology, ISSN 0022-3417, 07/2014, Volume 233, Issue 3, pp. 209 - 214
SMARCB1 | rhabdoid tumour | small cell carcinoma of the ovary | hypercalcaemic type | Pathology | Oncology | Life Sciences & Biomedicine | Science & Technology | Immunohistochemistry | Carcinoma, Small Cell - genetics | Humans | Ovarian Neoplasms - pathology | Rhabdoid Tumor - pathology | Exome | Ovarian Neoplasms - genetics | SMARCB1 Protein | Carcinoma, Small Cell - chemistry | Female | Nuclear Proteins - genetics | DNA Helicases - genetics | Hypercalcemia - genetics | Genetic Predisposition to Disease | Ovarian Neoplasms - chemistry | Hypercalcemia - pathology | Genetic Association Studies | Biomarkers, Tumor - analysis | Rhabdoid Tumor - chemistry | Hypercalcemia - metabolism | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Sequence Analysis, DNA | Chromosomal Proteins, Non-Histone - genetics | Phenotype | Rhabdoid Tumor - genetics | Biomarkers, Tumor - genetics | Mutation | Carcinoma, Small Cell - pathology | Carcinoma | Ovarian cancer | Cancer | Index Medicus
Journal Article
3.
Full Text
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
Cancer cell, ISSN 1535-6108, 02/2019, Volume 35, Issue 2, pp. 204 - 220.e9
SMARCB1 | autophagy | renal medullary carcinoma | MYC | embryonic mosaic GEM models | ER stress | BIRC5 | proteasome inhibitors | rhabdoid tumors | p53 | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Humans | Gene Expression Regulation, Neoplastic | SMARCB1 Protein - genetics | Male | Mice, 129 Strain | Rhabdoid Tumor - pathology | Autophagy - drug effects | Tumor Suppressor Protein p53 - genetics | Female | Antineoplastic Agents - pharmacology | Rhabdoid Tumor - metabolism | SMARCB1 Protein - deficiency | Tumor Cells, Cultured | Proteostasis - drug effects | Rhabdoid Tumor - drug therapy | Endoplasmic Reticulum Stress - drug effects | Proteasome Inhibitors - pharmacology | Signal Transduction | Mice, Inbred C57BL | Tumor Suppressor Protein p53 - metabolism | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Tumor Suppressor Protein p53 - deficiency | Unfolded Protein Response | Proto-Oncogene Proteins c-myc - metabolism | Mice, Knockout | Animals | Rhabdoid Tumor - genetics | Cell Line, Tumor | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Proto-Oncogene Proteins c-myc - genetics | Tumor proteins | Analysis | Tumors | Index Medicus
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 10/2011, Volume 35, Issue 10, pp. e47 - e63
malignant rhabdoid tumor | SMARCB1 | epithelioid sarcoma | schwannomatosis | SNF5 | soft tissue tumors | renal medullarycarcinoma | INI1 | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Myoepithelioma - metabolism | Kidney Neoplasms - genetics | Soft Tissue Neoplasms - diagnosis | Humans | Transcription Factors - deficiency | Carcinoma, Medullary - diagnosis | Carcinoma, Medullary - metabolism | Kidney Neoplasms - metabolism | DNA-Binding Proteins - deficiency | Kidney Neoplasms - diagnosis | DNA-Binding Proteins - metabolism | SMARCB1 Protein | Biomarkers, Tumor - metabolism | Sarcoma - diagnosis | Cytogenetic Analysis | Rhabdoid Tumor - metabolism | Sarcoma - genetics | Soft Tissue Neoplasms - genetics | Epithelioid Cells - pathology | Myoepithelioma - diagnosis | Chondrosarcoma - diagnosis | Chromosomal Proteins, Non-Histone - metabolism | Carcinoma, Medullary - genetics | Nerve Sheath Neoplasms - diagnosis | Soft Tissue Neoplasms - metabolism | Nerve Sheath Neoplasms - metabolism | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Chromosomal Proteins, Non-Histone - deficiency | Chromosomal Proteins, Non-Histone - genetics | Epithelioid Cells - metabolism | Immunohistochemistry - methods | Sarcoma - metabolism | Transcription Factors - metabolism | Rhabdoid Tumor - genetics | Rhabdoid Tumor - diagnosis | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 05/2006, Volume 24, Issue 15, pp. 2352 - 2358
Tumors of the urinary system | Nephrology. Urinary tract diseases | Biological and medical sciences | Kidneys | Medical sciences | Tumors | Prognosis | Prospective Studies | Kidney - pathology | Humans | Child, Preschool | Infant | Male | Rhabdoid Tumor - pathology | Nephrectomy | Vincristine - administration & dosage | Female | Child | Infant, Newborn | Kidney Neoplasms - therapy | Doxorubicin - administration & dosage | Anaplasia | Etoposide - administration & dosage | Dactinomycin - administration & dosage | Radiotherapy | Wilms Tumor - pathology | Rhabdoid Tumor - therapy | Wilms Tumor - therapy | Cyclophosphamide | Sarcoma, Clear Cell - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Kidney Neoplasms - pathology | Neoplasm Staging | Sarcoma, Clear Cell - therapy | Index Medicus
Journal Article
Urologic oncology, ISSN 1078-1439, 2016, Volume 34, Issue 1, pp. 50 - 56
Urology | Rhabdoid tumor | Pediatric renal cancer | Anaplastic Wilms tumor | p53 | P53 | Oncology | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Kidney Neoplasms - epidemiology | Prognosis | Standard of Care | Humans | Rhabdoid Tumor - pathology | Rhabdoid Tumor - epidemiology | Wilms Tumor - pathology | Rhabdoid Tumor - therapy | Wilms Tumor - therapy | Wilms Tumor - epidemiology | Carcinoma - epidemiology | Carcinoma - therapy | Kidney Neoplasms - pathology | Carcinoma - pathology | Child | Kidney Neoplasms - therapy | Sarcoma | Nephroblastoma | Pediatrics | Index Medicus
Journal Article
Pediatric and developmental pathology, ISSN 1093-5266, 1/2015, Volume 18, Issue 1, pp. 49 - 58
Malignant rhabdoid tumors | Schwannomatosis | SMARCB1 | AT/RT | Rhab-doid tumor predisposition syndrome | SMARCA4 | Pathology | Pediatrics | Life Sciences & Biomedicine | Science & Technology | Immunohistochemistry | Age Factors | Humans | Child, Preschool | Family Health | Infant | Male | Neurofibromatoses - genetics | SMARCB1 Protein | Neurilemmoma - genetics | Germ-Line Mutation | Female | Nuclear Proteins - genetics | Child | DNA Helicases - genetics | Infant, Newborn | Diagnosis, Differential | Genetic Predisposition to Disease | Rhabdoid Tumor - classification | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Chromosomal Proteins, Non-Histone - genetics | Rhabdoid Tumor - genetics | Skin Neoplasms - genetics | Rhabdoid Tumor - diagnosis | Index Medicus
Journal Article